Full Text View
Tabular View
No Study Results Posted
Related Studies
Internet-delivered Cognitive Behavioral Therapy (CBT) for Health Anxiety (Ha1b)
This study is currently recruiting participants.
Verified by Karolinska Institutet, August 2009
First Received: January 22, 2009   Last Updated: August 3, 2009   History of Changes
Sponsored by: Karolinska Institutet
Information provided by: Karolinska Institutet
ClinicalTrials.gov Identifier: NCT00828152
  Purpose

Hypochondriasis (health anxiety) is common, has many negative consequences for the afflicted individual and is associated with high societal costs. Cognitive Behavioural Therapy (CBT) has proven to be effective when administered in live-sessions. The aim of this study is to investigate whether CBT remains effective when administered via a self-help programme on the Internet.


Condition Intervention Phase
Hypochondriasis
Behavioral: Internet-delivered CBT.
Behavioral: On line discussion group
Phase II

Study Type: Interventional
Study Design: Treatment, Randomized, Open Label, Placebo Control, Parallel Assignment
Official Title: Internet-delivered Cognitive Behavioural Therapy for Health Anxiety - a Randomized Controlled Trial

Resource links provided by NLM:


Further study details as provided by Karolinska Institutet:

Primary Outcome Measures:
  • Health Anxiety Inventory [ Time Frame: pre, post, 6 and 12 month follow up ] [ Designated as safety issue: No ]

Secondary Outcome Measures:
  • Diagnostic Interview, Instruments to measure anxiety, depression, quality of life. [ Time Frame: pre, post, 6 and 12 month follow up ] [ Designated as safety issue: No ]

Estimated Enrollment: 80
Study Start Date: January 2009
Estimated Study Completion Date: July 2010
Estimated Primary Completion Date: June 2010 (Final data collection date for primary outcome measure)
Arms Assigned Interventions
1: Experimental
Internet-delivered CBT. Contact with therapist thru an e-mail system. 12 weeks.
Behavioral: Internet-delivered CBT.
12 weeks. Therapist contact thru e-mail.
2: Placebo Comparator
On line discussion group.
Behavioral: On line discussion group
Placebo. On line discussion group.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   No
Criteria

Inclusion Criteria:

  • Primary diagnosis of hypochondriasis
  • At least 18 years old
  • Able to read and write in swedish
  • Computer access

Exclusion Criteria:

  • Drug abuse
  • Concurrent severe depression
  • No serious somatic illness
  • Previous treatment with CBT for hypochondriasis
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00828152

Contacts
Contact: Erik Hedman, MS +468 585 857 91 erik.hedman@sll.se

Locations
Sweden
Psykiatri Sydväst Recruiting
Stockholm, Sweden, 141 86
Contact: Erik Hedman, MS     +478 585 857 91     erik.hedman@sll.se    
Sponsors and Collaborators
Karolinska Institutet
  More Information

No publications provided

Responsible Party: Psykiatri Sydväst ( Nils Lindefors )
Study ID Numbers: Ha1b
Study First Received: January 22, 2009
Last Updated: August 3, 2009
ClinicalTrials.gov Identifier: NCT00828152     History of Changes
Health Authority: Sweden: Regional Ethical Review Board

Study placed in the following topic categories:
Hypochondriasis
Mental Disorders
Somatoform Disorders

Additional relevant MeSH terms:
Hypochondriasis
Mental Disorders
Somatoform Disorders

ClinicalTrials.gov processed this record on September 10, 2009